UK lawmakers call Palantir's role in public sector an unacceptable weakness

A UK parliamentary committee has sharply criticized the government's increasing reliance on U.S. technology companies, singling out Palantir as an "unacceptable point of weakness" in its public sector strategy. The Science, Innovation and Technology Committee highlighted Palantir's significant presence in Britain, particularly its £330 million contract with the National Health Service (NHS), as a prime example of this overdependence.

The committee's report, spanning 70 pages, raised concerns about vendor lock-in and a "clear mismatch with UK values." It pointed to Palantir's history of supplying software for the U.S. military and immigration services, as well as the political views of its billionaire co-founder Peter Thiel, who has been critical of the concept of a national health service. The report stated that the government's digital ambitions could be jeopardized by decisions made by foreign commercial or state actors based on their own narrow interests.

While the committee can only make recommendations, its findings underscore a broader critique of the government's approach to digital transformation. The report concluded that the government lacks a cohesive plan for modernizing public services and described its aim to save £45 billion annually through digital changes as "worryingly optimistic." The committee also called for the appointment of a senior minister to lead the government's digital strategy.

Palantir, which has been approached for comment, secured its seven-year contract with the NHS in 2023. The committee urged the government to consider exercising a break clause within the agreement, emphasizing the need for greater control and alignment with British values in critical public sector technology contracts.